William Jones

Insider Reports History

Entity
Individual
Location
Nitromed, Inc., 125 Spring Street, Lexington, MA
Signature
/s/ Matthew Batters, as attorney-in-fact for William Jones
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William Jones:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Apogee Therapeutics, Inc. Director Common Stock 34.8K $1.3M $37.26 Jul 13, 2023 Direct
Akili, Inc. Director Stock Option (Right to Buy) 22K May 2, 2023 Direct
Apogee Therapeutics, Inc. Director Stock Option (Right to Buy) 10.4K Jun 5, 2024 Direct
Biohaven Pharmaceutical Holding Co Ltd. CCO-Migraine & Common Disease Common Shares 0 $148.50 Oct 3, 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. CCO-Migraine & Common Disease Restricted Share Unit Award 0 Oct 3, 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. CCO-Migraine & Common Disease Stock Options (Right to Buy) 0 Oct 3, 2022 Direct

Insider Reports Filed by William Jones

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APGE Apogee Therapeutics, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
NAMS NewAmsterdam Pharma Co N.V. Apr 25, 2024 0 $0 3 May 3, 2024 Chief Commercial Officer
APGE Apogee Therapeutics, Inc. Jul 13, 2023 0 $0 3/A Jul 17, 2023 Director
AKLI Akili, Inc. May 2, 2023 1 $0 4 May 4, 2023 Director
AKLI Akili, Inc. Nov 2, 2022 1 $0 4 Nov 4, 2022 Director
BHVN Biohaven Pharmaceutical Holding Co Ltd. Oct 3, 2022 12 -$2.11M 4 Oct 3, 2022 CCO-Migraine & Common Disease
AKLI Akili, Inc. Aug 19, 2022 0 $0 3 Aug 19, 2022 Director
BHVN Biohaven Pharmaceutical Holding Co Ltd. Jan 6, 2022 8 -$486K 4 Jan 7, 2022 CCO-Migraine & Common Disease
BHVN Biohaven Pharmaceutical Holding Co Ltd. Nov 25, 2021 3 -$151K 4 Nov 26, 2021 CCO-Migraine & Common Disease